-
1.
公开(公告)号:EP3418393A1
公开(公告)日:2018-12-26
申请号:EP17753458.3
申请日:2017-02-15
申请人: Nuribio Co., Ltd.
发明人: NAM, Young Hyean
IPC分类号: C12Q1/68 , G01N33/533
CPC分类号: C12Q1/68 , G01N33/533
摘要: The present invention relates to a promer that has a structure of X-Y-Z and that comprises a detectable marker attached to both ends or the inside thereof and also that is used as a primer and a probe during real-time detection of nucleic acid or protein, and to a method for real-time detection of nucleic acid, comprising amplifying a nucleic acid to be detected using the promer, and then measuring the amount of fragments of the promer cleaved, or to a method for real-time detection of protein. The method for detection of nucleic acid or protein according to the present invention uses a small amount of oligos compared to a conventional detection method, does not require a separate probe for real-time detection, and thus can achieve real-time detection of the nucleic acid or protein to be detected in a cost-effective and simple manner. Furthermore, mutations in the Y region can be detected through amplification after cleavage of the Y region of the promer, and multiplex detection of nucleic acids or proteins larger than the number of fluorescent labels attached to the promer is possible. Thus, the present invention can be effectively used for diagnosis of various diseases and for prognostic diagnosis.
-
公开(公告)号:EP3404101A3
公开(公告)日:2018-12-26
申请号:EP18182250.3
申请日:2012-12-21
发明人: LEE, Kwang Ho , LIM, Sang Jo , MOON, Jun Ok , JANG, Jae Woo , PARK, Su Jin , PARK, Sang Hee
CPC分类号: C12P13/08 , C12N9/1022 , C12N9/1217 , C12N9/93 , C12N15/52 , C12N15/63 , C12N15/74 , C12Y202/01001 , C12Y207/02004 , C12Y604/01001 , Y02P20/52
摘要: The present invention relates to a modified polynucleotide encoding aspartate kinase (EC:2.7.2.4; hereinafter, referred to as LysC), transketolase (EC:2.2.1.1; hereinafter, referred to as Tkt) or pyruvate carboxylase (EC:6.4.1.1; hereinafter, referred to as Pyc), in which the initiation codon is substituted with ATG, a vector including the same, a microorganism transformed with the vector, and a method for producing L-lysine using the same.
-
公开(公告)号:EP3409394A1
公开(公告)日:2018-12-05
申请号:EP17760153.1
申请日:2017-03-02
发明人: NAKAMURA, Naofumi , YAMAMOTO, Yudai
摘要: An object of the present invention is to provide a method for manufacturing a molded member, which can maintain high accuracy circularity of an inner diameter of a tubular body even if a thickness of a base metal sheet varies and which can prevent occurrence of adhesion, seizure of the like of the base metal sheet to a die used for finishing ironing. The base metal sheet is subjected to multi-stage drawing to manufacture the molded member including a tubular body and a flange formed at an end portion of the body. The multi-stage drawing includes: preliminary drawing for forming a preliminary body having a body element from the base metal sheet; at least one compression drawing performed after the preliminary drawing and forming the body by drawing the body element while applying a compressive force to the body element; and at least one finishing ironing performed after the at least one compression drawing to ensure dimensional accuracy.
-
公开(公告)号:EP3402823A2
公开(公告)日:2018-11-21
申请号:EP17738869.1
申请日:2017-01-11
申请人: Inhibrx, Inc.
发明人: ECKELMAN, Brendan P. , TIMMER, John C. , HATA, Chelsie , JONES, Kyle S. , HUSSAIN, Abrahim , RAZAI, Amir S. , BECKLUND, Bryan , PANDIT, Rajay , KAPLAN, Mike , RASON, Lucas , DEVERAUX, Quinn
IPC分类号: C07K16/28 , C07K14/705 , A61K39/395
CPC分类号: C07K16/2878 , C07K16/2827 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/35 , C07K2317/52 , C07K2317/569 , C07K2317/75 , C07K2317/76 , C07K2317/92 , C07K2319/00
摘要: This invention relates generally to molecules that specifically engage 41BB, a member of the TNF receptor superfamily (TNFRSF). More specifically, this invention relates to multivalent and multispecific molecules that bind at least 41BB.
-
公开(公告)号:EP3401033A1
公开(公告)日:2018-11-14
申请号:EP17756457.2
申请日:2017-02-21
发明人: NAKAMURA, Naofumi , YAMAMOTO, Yudai
IPC分类号: B21D22/28
摘要: Provided is a method for producing a molded material by molding processes including at least one drawing-out process and at least one drawing process performed after the drawing-out process, in which a width of a punch 31 used in the drawing-out process on a rear end side is wider than a width of the punch on a distal end side, and an ironing process is performed on a region corresponding to a flange of a base metal sheet 2 by pushing the base metal sheet together with the punch 31 into a pushing hole 30a, and the drawing process is carried out using a die and a drawing sleeve, and processing is performed on a region subjected to the ironing process in the drawing-out process, while maintaining a constant mold gap between the die and the drawing sleeve.
-
6.
公开(公告)号:EP3361257A1
公开(公告)日:2018-08-15
申请号:EP17193573.7
申请日:2017-09-27
发明人: LIN, Chieh-Hsin , LANE, Hsien-Yuan
摘要: A method for diagnosing Alzheimer's disease (AD) includes the steps of: determining a biomarker level in a blood sample from a human subject suspected of having AD, the biomarker level being selected from the group consisting of a G72 protein level, an SLC7A11 mRNA expression level, and a combination thereof; comparing the biomarker level with a predetermined standard therefor; wherein an increase in the biomarker level relative to the predetermined standard therefor is indicative of AD in the human subject. A kit for diagnosing AD includes a material for determining the biomarker level and instructions for using the kit.
-
公开(公告)号:EP3348274A1
公开(公告)日:2018-07-18
申请号:EP18160919.9
申请日:2014-02-03
发明人: KIM, Dae Jin , LEE, Byung Sun , KIM, Seung Su , HWANG, Sang Youn , CHOI, In Young , KWON, Se Chang
CPC分类号: A61K38/4846 , A61L2/16 , C12Y304/21021 , A61K2300/00
摘要: The present invention relates to a method for inactivating viruses in a composition comprising blood coagulation factor VII, and more particularly, to a method for inactivating viruses comprising adding a surfactant to a composition comprising blood coagulation factor VII or a derivative thereof and a method for preparing a virus-inactivated composition comprising blood coagulation factor VII or the derivative thereof.
-
公开(公告)号:EP3341085A1
公开(公告)日:2018-07-04
申请号:EP16840403.6
申请日:2016-08-26
申请人: Safetylink Pty Ltd
发明人: POLDMAA, Arvo
CPC分类号: A62B35/0081 , A62B35/0075 , E04G21/3261 , E04G21/329 , E04G21/3295
摘要: The present invention is directed to a shuttle device for a height safety system, the device including a first member having an inner wall defining a recess, the inner wall terminating at two sides to define a first opening. The device further includes a second member received in the recess of the first member, the second member being slidable relative to the first member to facilitate movement of the device between a locked condition and an unlocked condition. In the locked condition, the second member and a side of the inner wall define a second opening, the second opening being smaller than the first opening.
-
公开(公告)号:EP3006455B1
公开(公告)日:2018-07-04
申请号:EP14804503.2
申请日:2014-05-29
发明人: JUNG, Sung Youb , HUH, Yong Ho , PARK, Sung Hee , LEE, Jong Soo , CHOI, In Young
CPC分类号: A61K38/193 , A61K47/60 , A61K47/68 , A61K47/6813 , A61K47/6849 , C07K14/47 , C07K16/2803 , C07K2317/40 , C07K2317/52 , C07K2317/53 , C07K2317/94 , C07K2319/30
摘要: The present invention relates to a modified IgG4 Fc fragment useful as a drug carrier. When the modified IgG4 Fc fragment of the present invention is combined with an arbitrary drug, the resulting drug conjugate can minimize the effector functions of the IgG4 Fc and the chain exchange with in vivo IgG while maintaining in vivo activity and improving in vivo duration of the drug conjugate.
-
10.
公开(公告)号:EP3330259A1
公开(公告)日:2018-06-06
申请号:EP16830837.7
申请日:2016-07-27
发明人: LEE, Jaekwang , KO, Moo Sung , HAN, Younghue , KIM, Yuntae
IPC分类号: C07D271/10 , C07D413/10 , C07D413/12 , A61K31/4245
CPC分类号: C07D413/10 , A61K31/4245 , C07D205/04 , C07D213/02 , C07D271/10 , C07D413/12
摘要: The present invention relates to novel compounds having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present invention have histone deacetylase 6 (HDAC6) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases, including infectious diseases; neoplasms; endocrine, nutritional and metabolic diseases; mental and behavioral disorders; neurological diseases; diseases of the eye and adnexa; cardiovascular diseases; respiratory diseases; digestive diseases; diseases of the skin and subcutaneous tissue; diseases of the musculoskeletal system and connective tissue; or congenital malformations, deformations and chromosomal abnormalities.
-
-
-
-
-
-
-
-
-